Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice

Journal of Neuroimmunology

Volumn 130, Issue 1-2, 2002, Pages 109-116

  Rosignoli, Florencia ^a   Pérez Leirós, Claudia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autoimmune sialadenitis; Nitric oxide; NOD mice; NOS isoforms; Salivary glands; VIP signaling

Indexed keywords

AMYLASE; NITRIC OXIDE SYNTHASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; IMMUNE SYSTEM; INFLAMMATION; MOUSE; NERVOUS SYSTEM; NONHUMAN; PAROTID GLAND; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN SECRETION; SALIVA LEVEL; SALIVATION; SIALOADENITIS; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

AGE FACTORS; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NEUROIMMUNOMODULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PARASYMPATHETIC FIBERS, POSTGANGLIONIC; PROTEIN ISOFORMS; RECEPTORS, MUSCARINIC; SALIVA; SALIVARY GLANDS; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036709645     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00223-0     Document Type: Article

References (47)

1. Amin A.R., Attur M., Abramson S.B. Nitric oxide synthase and cyclooxygenases: distribution, regulation and intervention in arthritis. Curr. Opin. Rheumatol. 11:1999;202-209.
2. 3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest. Ophthalmol. Visual Sci. 39:1998;151-156.
3. Bernfeld P. Amylase, alpha and beta. Methods Enzymol. 1:1955;149-158.
4. Borda E.S., Pérez Leirós C., Sterin Borda L., Bracco M.M.E. Cholinergic response of isolated rat atria to recombinant rat interferon-gamma. J. Neuroimmunol. 32:1991;53-59.
5. +2-dependent nitric oxide synthase activity in human astrocytoma cells. J. Biol. Chem. 272:1997;7582-7585.
6. Dawson T.M., Snyder S. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5159.
7. Dehaye J.P., Christophe J., Ernst F., Poloczek P., van Bogaert P. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands. Arch. Oral Biol. 30:1985;827-832.
8. Ekström J., Mansson B., Tobin G. Vasoactive intestinal peptide induces salivary secretion in the rat. J. Physiol. (Lond.). 332:1982;. 76 pp.
9. Ekström J., Mansson B., Tobin G. Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity. Acta Physiol. Scand. 119:1983;169-175.
10. Förstermann U., Boissel J.P., Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12:1998;773-790.
11. Fox R.I., Michelson P. Approaches to the treatment of Sjögren's syndrome. J. Rheumatol. 27:2000;15-21.
12. Goetzl E.J., Pankhaniya R.R., Gaufo G.O., Mu Y., Xia M., Sreedharan S.P. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann. N. Y. Acad. Sci. U.S.A. 840:1998;540-550.
13. Goin J.C., Perez Leiros C., Borda E., Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J. 10:1997;77-83.
14. Hodges R.H., Zoukhri D., Sergheraert C., Zieske J.D., Dartt D.A. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest. Ophthalmol. Visual Sci. 38:1997;610-619.
15. Hu Y., Nakagawa Y., Purshotham K., Humphreys-Beher M.G. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263:1992;E607-E614.
16. Hu Y., Purushotham K.R., Wang P.L., Dawson R., Humphreys-Beher M.G. Down-regulation of β adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am. J. Physiol. 266:1994;G433-G443.
17. Humphreys-Beher M.G., Hu Y., Nakagawa Y., Wang P.L., Purushotham K.R. Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome. Adv. Exp. Med. Biol. 350:1994;631-637.
18. Inoue Y., Kaku K., Kaneko T., Yanahara N., Kanno T. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′-5′-monophosphate. Endocrinology. 116:1985;686-692.
19. Jacobsson L.T.H., Manthorpe R. Epidemiology of Sjögren's syndrome. Rheumatol. Eur. 24:1995;46-47.
20. Kong L., Robinson C.P., Peck A.B., Vela-Roch N., Sakata K.M., Dang H., Talal N., Humpherys-Beher M.G. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin. Exp. Rheumatol. 16:1998;675-681.
21. Kontinnen Y.T., Platts L.A.M., Tuominen S., Eklund K.K., Santavirta N., Törnwall J., Sorsa T., Hukkanen M., Polak J.M. Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum. 40:1997;875-883.
22. Lohinai Z., Burghardt B., Zelles T., Varga G. Nitric oxide modulates salivary amylase and fluid, but not epidermal growth factor secretion in conscious rats. Life Sci. 64:1999;953-963.
23. Lomniczi A., Suburo A.M., Elverdin J.C., Mastronardi C.A., Diaz S., Rettori V., McCann S.M. Role of nitric oxide in salivary secretion. Neuroimmunomodulation. 5:1998;226-233.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Lundberg J.M., Anggard A., Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. Acta Physiol. Scand. 114:1982;329-337.
26. Mitsui Y., Furuyama S. Characterization of nitric oxide synthase in the rat parotid gland. Arch. Oral Biol. 45:2000;531-536.
27. Miyagawa J. Ultrastructural and immunocytochemical submandibulitis in the non-obese diabetic (NOD) mouse. Virchows Arch. (Cell. Pathol.). 51:1986;215-225.
28. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
29. Murthy K.S., Zhang K.-M., Jin J.G., Grider J.R., Makhlouf G.M. VIP-mediated G protein-coupled Ca+2 influx activates a constitutive NOS in dispersed gastric muscle cells. Am. J. Physiol. 265:1993;G660-G671.
30. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
31. Perez Leiros C., Goren N., Sterin-Borda L., Lustig L., Borda E.S. Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clin. Aut. Res. 4:1994;249-255.
32. Pérez Leirós C., Sterin Borda L., Borda E.S., Goin J.C., Hosey M.M. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J. Biol. Chem. 272:1997;12989-12993.
33. Perez Leiros C., Goren N., Sterin-Borda L., Borda E.S. Myocardial Dysfunction in an experimental model of autoimmune myocarditis: role of IFN gamma. Neuroimmunomodulation. 4:1998;91-97.
34. Perez Leiros C., Sterin-Borda L., Hubscher O., Arana R., Borda E. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies. Clin. Immunol. 90:1999;190-195.
35. Perez Leiros C., Rosignoli F., Genaro A.M., Sales M.E., Sterin-Borda L., Borda E.S. Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands. J. Aut. Nerv. Syst. 79:2000;99-107.
36. Pozo D., Delgado M., Martínez C., Guerrero J.M., Leceta J., Gomariz R., Calvo J.R. Immunobiology of vasoactive intestinal peptide (VIP). Immunol. Today. 21:2000;7-11.
37. Robberecht P., Waelbroeck M. A critical view of the methods for characterization of the VIP/PACAP receptor subclasses. Ann. N. Y. Acad. Sci. 865:1998;157-163.
38. Roitt I.M., Brostoff J., Male D. Autoimmunity and autoimmune disease. Immunology. 1998;367-380 Mosby International, London.
39. Rosignoli F., Goren N., Perez Leiros C. Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice. Clin. Immunol. 101:2001;86-93.
40. Rosignoli F., Pérez Leirós C. Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland. Eur. J. Pharmacol. 439:2002;27-33.
41. Sterin-Borda L., Pérez Leirós C., Borda E.S., Bracco M.M.E. Effects of IL2 on the myocardium. Participation of the sympathetic system. J. Mol. Cell. Cardiol. 28:1996;2457-2465.
42. Strand V., Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull. Rheum. Dis. 92:1980;212-226.
43. Turner J.T., Bylund D.B. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations. J. Pharmacol. Exp. Ther. 242:1987;873-881.
44. Turner J.T., Camden J.M. Regulation of secretion by vasoactive intestinal peptide in isolated perfused rat submandibular glands. Arch. Oral Biol. 37:1992;281-287.
45. Yamamoto H., Sims N.E., Macauley S.P., Nguyen K.H.T., Nakagawa Y., Humphreys-Beher M.G. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin. Immunol. Immunopathol. 78:1996;245-255.
46. Yamamoto H., Ishibashi K., Nakagawa Y., Maeda N., Zeng T., Robinson C.P., Oxford G.E., Chegini N., Humphreys-Beher M.G. Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis. Scand. J. Immunol. 45:1997;55-61.
47. Yamano S., Atkinson J.C., Baum B.J., Fox P.C. Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin. Immunol. 92:1999;265-275.